β(1-3)(1-6)-D-glucans Modulate Immune Status and Blood Glucose Levels in Dogs

Journal Title: Journal of Pharmaceutical Research International - Year 2014, Vol 4, Issue 8

Abstract

Aims: The objective of this study is to evaluate the effects of adding two different glucans coded as BGO1 and BGO2 into commercial feed of dogs. Study Design: We measured changes in phagocytosis, levels of IL-2 in blood, antibody formation and level of blood sugar (normal homeostasis and experimentally-induced hyperglycaemie with streptozotocin). Place and Duration of Study: Department of Pathology, University of Louisville, and Department of Research and Development, Biorigin, June 2012 and May 2013. Methodology: The technique employing phagocytosis of synthetic polymeric microspheres was used for evaluation of phagocytic activity. IL-2 production was evaluated in serum by an ELISA kit. Formation of antibodies was tested using ovalbumin as an antigen, level of specific antibodies was measured by ELISA. Blood sugar evaluation was done both in normal animals and in animals with experimentally-induced hyperglycaemie. The level of glucose in serum was measured by Antech Diagnostics. Results: In phagocytosis, both glucans significantly (P ≤0.05 level) increased the phagocytic activity of blood monocytes and neutrophils. Both glucans were active in IL-2 tests, but BG01 activity was 160% of that of BG02. Similar data were achieved in evaluation of effects on antibody response – BG01 reached OD of 0.717, whereas BG02 reached OD 0.411. Blood sugar evaluations showed no effect of glucan on normal dogs, but significant (P ≤0.05 level) reduction in dogs with hyperglycaemie (both glucans showed same activity). Conclusion: Our data showed that both glucans had significant immunomodulating effects in immune reactions in the dog model, strongly suggesting that supplementation of feed with these glucans results in improvement of biological and immunological conditions of dogs.

Authors and Affiliations

Vaclav Vetvicka, Carlos Oliveira

Keywords

Related Articles

Health Care Provider Hormonal Recommendations for Treatment of Menstrual Cycle-related Problems - A Vignette-based Study

Background: Combined hormonal contraceptives (CHC) are recommended for “non-contraceptive benefits” for menstrual cycle-related problems. But no evidence-based consensus exists. Our purpose was to assess the clinical cho...

An Experimental Study to Evaluate Hepatoprotective Activity of Herbal Formulation in Rats

Objective: To study the hepatoprotective activity of herbal formulation against CCl4 induced hepatoxicity in rats. Materials and Methods: Twenty four Charles Foster albino rats of either sex, weighing 150-200 g were div...

Medicinal Values of Trichosanthus cucumerina L. (Snake Gourd) - A Review

Snake gourd is an annual climber and it’s commonly called as snake gourd, viper gourd, snake tomato or long tomato. The fruit is usually consumed as a vegetable due to it is good nutritional value. The fruit is a good so...

A Review on Tablet Scoring: Background, History and Current Regulatory Considerations

Tablet splitting or breaking of tablets into multiple strengths has been a common practice across the world. Splitting of tablet offers various advantages such as dose flexibility and ease of swallowing in different popu...

In vitro Genotoxic Effect of Arsenical Compounds in HepG2 Liver Cells

Aims: The aim of this study was to determine the genotoxic effect in HepG2 cells of the four arsenic compounds by measuring DNA damage, depletion of cellular glutathione (GSH) as a measure of oxidative stress as well as...

Download PDF file
  • EP ID EP344954
  • DOI 10.9734/BJPR/2014/7862
  • Views 114
  • Downloads 0

How To Cite

Vaclav Vetvicka, Carlos Oliveira (2014). β(1-3)(1-6)-D-glucans Modulate Immune Status and Blood Glucose Levels in Dogs. Journal of Pharmaceutical Research International, 4(8), 981-991. https://www.europub.co.uk/articles/-A-344954